GenoLogics has announced recent additions to its management team in the areas of sales, product development, marketing and finance to support the business expansion and growth strategy of the company
Michael Ball, CEO, said: "GenoLogics is now very well positioned to take advantage of increasing demand for its products in a rapidly growing market.
"The management team brings a depth of knowledge and skills in leading technology start-ups and growing businesses internationally, managing complex software development, building a global market presence and developing strategic partnerships that will enable GenoLogics to accelerate its growth".
Greg Kinch, VP sales, joins GenoLogics from Silicon Genetics (now owned by Agilent).
He previously held sales leadership positions at Genomic Solutions, BI Systems, and other companies in the life sciences industry.
His expertise in the proteomics and genomics markets will drive GenoLogics business growth in these markets.
Joining GenoLogics as VP product development, Rob Milne brings over 20 years experience in engineering and business management, previously holding engineering and R and D executive positions with Nokia, Vienna Systems, Motorola and Mitel.
He has demonstrated ability in building technology organisations from start-up to successful business ventures.
Gail McBride, VP marketing joins GenoLogics with leadership experience in marketing at ALI Technologies (now owned by McKesson), and marketing/international business development roles at HA Simons (now Amec) and other organisations.
She helped ALI expand its market presence in the radiology image management market, making it an attractive investment for McKesson.
David Slater-Kinghorn assumes the role of VP finance.
He is a CA, holds a bachelor of laws degree and brings international experience in financial leadership and operational management at companies including LifeScan Canada, a Johnson and Johnson company, CanWel Distribution and Sappi Export Services.
Brandie Yarish is manager human resources and brings a wealth of experience in HR management, leadership development and recruitment in several high growth technology companies, including Power Measurement and ACD Systems.
Rounding out the management team is James DeGreef, co-founder of GenoLogics who led the start-up and development of the company until the appointment of Michael Ball as CEO in September 2004.
DeGreef assumes the role of VP product management to lead the product vision and roadmap.
Michael Ball, CEO, has 20 years experience in sales, marketing and business development with technology companies, including five years in executive management with Creo Products as VP business development and VP European sales and service.
In addition to his Creo experience, Ball was VP at Carmanah Technologies, spent seven years at Digital Equipment, and has experience with several technology start-ups.
Ball was instrumental in securing the recent round of venture capital financing for GenoLogics.
"GenoLogics sales have been driven by the increasing need of life science and pharmaceutical research facilities to manage the explosion of information generated by proteomics research," said Michael Ball.
"Proteomics researchers and lab managers have been frustrated with the lack of a solution to manage their processes and the unprecedented data volumes.
"GenoLogics software solves these real world problems and helps researchers accelerate development and advances in health research and drug discovery.
"We now have all the elements in place to be extremely successful in this emerging market, including a dynamic management team, financial backing, an installed base of prominent academic and pharmaceutical customers to build upon and an increasing demand in North America and Europe for our product.
"The future is very bright for GenoLogics".
GenoLogics develops bioinformatics software that helps life science and pharmaceutical laboratories, specialising in the field of proteomics and systems biology research, to manage, integrate and analyse enormous volumes of scientific and lab data to advance health science research and drug discovery.
More than a workflow system, ProteusLims is a comprehensive and integrated lab, instrument, and scientific data management system that transform the data management process into a sophisticated analytical system to aid research and scientific discovery.
OmixLims is an enabling software platform for systems biology research.
The company is headquartered in Victoria, BC, Canada.
